I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78% Market Closed
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

InDex Pharmaceuticals Holding AB
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InDex Pharmaceuticals Holding AB
Cash from Financing Activities Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
MOB

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Cash from Financing Activities
kr572.3m
CAGR 3-Years
6%
CAGR 5-Years
74%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Cash from Financing Activities
kr196.1m
CAGR 3-Years
N/A
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Cash from Financing Activities
kr1.3B
CAGR 3-Years
45%
CAGR 5-Years
22%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Cash from Financing Activities
-kr298.5m
CAGR 3-Years
N/A
CAGR 5-Years
-99%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Cash from Financing Activities
kr23.7m
CAGR 3-Years
-55%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Cash from Financing Activities
kr92.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InDex Pharmaceuticals Holding AB's Cash from Financing Activities?
Cash from Financing Activities
572.3m SEK

Based on the financial report for Jun 30, 2024, InDex Pharmaceuticals Holding AB's Cash from Financing Activities amounts to 572.3m SEK.

What is InDex Pharmaceuticals Holding AB's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
74%

The average annual Cash from Financing Activities growth rates for InDex Pharmaceuticals Holding AB have been 6% over the past three years , 74% over the past five years .

Back to Top